Cargando…
Liposomes for Targeted Delivery of Active Agents against Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease)
Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease represent a huge unmet medical need. The prevalence of both diseases is increasing, but the efficacy of treatment is still very limited due to various factors including the blood brain barrier (BBB). Drug deliv...
Autores principales: | Spuch, Carlos, Navarro, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238398/ https://www.ncbi.nlm.nih.gov/pubmed/22203906 http://dx.doi.org/10.1155/2011/469679 |
Ejemplares similares
-
Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases()
por: Pandian, Sureshbabu Ram Kumar, et al.
Publicado: (2022) -
LRP-1 and LRP-2 receptors function in the membrane neuron. Trafficking mechanisms and proteolytic processing in Alzheimer's disease
por: Spuch, Carlos, et al.
Publicado: (2012) -
Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases
por: Chin-Chan, Miguel, et al.
Publicado: (2015) -
Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer’s Disease and Parkinson’s Disease)
por: Włodarek, Dariusz
Publicado: (2019) -
Liposome delivery systems for the treatment of Alzheimer’s disease
por: Ross, Callum, et al.
Publicado: (2018)